Stockscreener 앱 받기
99.29
1.50%
-1.51
시간 외 거래:
100.00
0.71
+0.72%
Illumina Inc 주식(ILMN)의 최신 뉴스
Another FCA Cybersecurity Settlements Highlight DOJ’s Enforcement Priorities - JD Supra
New Empirical Research Report on Human Microbiome Sequencing - openPR.com
Immune Repertoire Sequencing Market Outlook (2025-2032): - openPR.com
Illumina names Nilesh Shah as head of region, AMEA - Medical Buyer
Risk adjusted return profile for Illumina Inc. analyzedEarnings Overview Report & AI Forecasted Entry and Exit Points - Newser
Ranking Illumina Inc. among high performing stocks via toolsJuly 2025 Volume & Technical Entry and Exit Tips - Newser
Nilesh Shah joins Illumina as Head of Region, AMEA - BioSpectrum Asia
Using R and stats models for Illumina Inc. forecasting2025 Technical Overview & Growth Focused Stock Reports - Newser
Chart based exit strategy for Illumina Inc.Fed Meeting & Growth Focused Stock Pick Reports - Newser
Will Illumina Inc. stock recover after recent dropChart Signals & High Accuracy Swing Trade Signals - Newser
Real time breakdown of Illumina Inc. stock performanceJobs Report & Momentum Based Trading Signals - Newser
Volatility clustering patterns for Illumina Inc.Bond Market & AI Forecasted Entry and Exit Points - Newser
Applying Elliott Wave Theory to Illumina Inc.Earnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Icahn exits Illumina, Dana; boosts stakes in CVR Energy - MSN
How to monitor Illumina Inc. with trend dashboardsShare Buyback & High Accuracy Trade Alerts - Newser
What to expect from Illumina Inc. in the next 30 daysTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - Newser
Illumina sets an example in disability inclusion - Illumina
Is Illumina Inc. stock heavily shortedWeekly Investment Summary & Verified Chart Pattern Signals - classian.co.kr
How to manage a losing position in Illumina Inc.July 2025 EndofMonth & Daily Profit Focused Screening - Newser
How to forecast Illumina Inc. trends using time seriesTrade Analysis Report & Fast Momentum Entry Tips - Newser
Best data tools to analyze Illumina Inc. stockQuarterly Trade Report & Growth Focused Entry Reports - Newser
Statistical indicators supporting Illumina Inc.’s strengthMarket Performance Report & Daily Risk Controlled Trade Plans - Newser
Price action breakdown for Illumina Inc.Swing Trade & AI Based Buy/Sell Signal Reports - Newser
The future of precision oncology: Scaling NGS with smarter variant interpretation - Illumina
What candlestick patterns are forming on Illumina Inc.2025 Market Outlook & Community Verified Trade Alerts - Newser
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina - ADVFN Brasil
Is Illumina Inc. on track to beat earningsJuly 2025 Summary & High Accuracy Swing Entry Alerts - newsyoung.net
Carl Icahn raises shared share stake in Centuri Holdings, dissolves in Dana, Illumina - MarketScreener
Carl Icahn Exits Dana, Illumina, Increases CVR Energy Stake in Q2 - AInvest
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
Now that NGS is more affordable, how can we make it easier? - Illumina
Illumina shares rise 1.18% premarket after Daiwa Securities downgrades to Neutral from Outperform. - AInvest
Illumina’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Illumina (NASDAQ:ILMN) Downgraded by Daiwa Capital Markets to Neutral - Defense World
Illumina Settles $9.8M False Claims Case Over Vulnerable Genomic Systems - WebProNews
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - TradingView
Illumina Downgraded to Neutral by Daiwa Securities - AInvest
Illumina Sees Future Rebound in China Sales - San Diego Business Journal
Daiwa Securities Downgrades Illumina to Neutral From Outperform, Adjusts Price Target to $94 From $124 - MarketScreener
US Personalized Medicine Market Trends and Company Analysis - GlobeNewswire
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
How Illumina Inc. stock performs during market volatilityMaximum Yield Stock Screener - classian.co.kr
Standard BioTools Announces SomaLogic Sale to Illumina - TipRanks
Latest Cybersecurity False Claims Act Settlement with Diagnostics Provider Focuses on Sensitive Health Systems - Inside Privacy
Illumina price leans on SMA supportForecast today11-08-2025 - Economies.com
DNA Microarray Market to Grow at 9% CAGR, Driven by Personalized - openPR.com
Single Cell Genome Sequencing Market is evolving rapidly Through 2025 To 2032 | Illumina, Inc., Fludigim Corporation - openPR.com
What MACD and RSI say about Illumina Inc.Daily Swing Candidate Analysis with Chart Patterns - Newser
Is Illumina Inc. a strong growth stockEarnings Surprise Driven Picks - thegnnews.com
What makes Illumina Inc. stock price move sharplyMulti-Sector Diversified Watchlist - thegnnews.com
What are analysts’ price targets for Illumina Inc.Weekly Oversold Bounce Candidates - thegnnews.com
DOJ Settlement With Medical Technology Company Signals Expanding Cybersecurity FCA Risk for Life Sciences Companies - JD Supra
Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues - simplywall.st
An introduction to the Illumina 5-Base Solution - Illumina
Detecting price anomalies in Illumina Inc. with AIShort-Term Swing Opportunity Summary Sheet - Newser
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Settles With DOJ, Veterans to End Whistleblower Lawsuit Over Genomic Sequencing Systems with Cybersecurity Vulnerabilities - AInvest
2.12%
0.82%
자본화:
|
볼륨(24시간):